Rapid Microbiology Testing Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS24042401 | Research Suite: Report (PDF) & Market Data (Excel)
Analysis of microorganisms, including bacteria,
viruses, fungi, and parasites, is a part of microbiology testing. It is carried
out for several reasons, including determining the effectiveness of medications
and medical supplies, monitoring the safety of food and water, identifying
infectious illnesses, and evaluating environmental contaminants. Culturing
microorganisms on agar plates, microscopic analysis, biochemical testing,
molecular techniques such as PCR (Polymerase Chain Reaction), immunological
assays, and sequencing procedures are examples of common approaches. The goal
of rapid microbiological testing is to deliver findings in minutes or even
hours.
Rapid Microbiology Testing Market
Global estimates for the rapid microbiology testing market point to a huge expansion; by 2034, the market is expected to be valued at USD 13,575.2 million, a major rise from the projected USD 5,428.0 million in 2023. Between 2024 and 2034, this growth trajectory is anticipated to sustain a strong compound annual growth rate (CAGR) of about 9.6%. The market is driven by the demand for quick and precise diagnostic techniques, the incidence of infectious illnesses, and growing concerns about food safety. The need for quick microbiological testing in clinical settings has increased due to the growth in infectious disease incidence worldwide.
Acute Respiratory Diseases
(ARDs) are one of the world's main causes of microbial infection and mortality,
accounting for around 4.3 million deaths yearly, according to NHI estimates
(2023). For infectious disease outbreaks to be contained and treated promptly,
prompt and accurate diagnosis is essential. Because of their large concentration
of industry leaders and continuous technical developments, the United States
and Canada are important drivers of the market's growth.
Rapid Microbiology Testing Market Growth Drivers:
Fast diagnosis of infectious disorders by rapid
microbiological testing facilitates prompt treatment start and better patient
outcomes for medical professionals. To effectively prescribe antibiotics and
stop the spread of resistant types of bacteria in the age of antimicrobial
resistance (AMR), pathogens must be identified quickly. Hospital stays,
diagnostic times, and the danger of transmission in healthcare settings are all
decreased by being able to get actionable findings in hours as opposed to days.
The demand for strict food safety laws and quick
microbiological testing methods is fueled by the serious health concerns that
foodborne infections represent to the global population. Governments and
regulatory bodies enforce stringent guidelines on food producers and processors
to guarantee the security and caliber of food items. By using rapid testing
techniques, food firms stop foodborne outbreaks and product recalls by
identifying microbiological contaminants including Salmonella, E. Coli, and
Listeria in raw materials, final goods, and processing environments.
Rapid microbiological testing has been transformed
by technological breakthroughs, which have resulted in the creation of creative
platforms and automated systems that improve throughput, accuracy, efficiency,
and efficiency. Next-generation sequencing (NGS), PCR, MALDI-TOF MS, and other
molecular diagnostic methods provide very sensitive, fast, and precise microbe
identification. Automation and workflow optimization in laboratories are made
possible by the integration of robots, microfluidics, and artificial
intelligence (AI). The use of quick microbiological testing is expanded across
several industries, such as pharmaceuticals, food, healthcare, and
environmental monitoring, by these technical advancements that also reduce
operating costs and enhance testing speed and accuracy.
Rapid Microbiology Testing Market Segmentation:
·
By Product Type: Instruments, Reagents & Kits, Consumables
·
By Testing Method: Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid
Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing,
Viability-Based Rapid Microbiology Diagnostic Testing, Other Rapid Microbiology
Testing Methods
·
By Application: Clinical Disease Diagnosis, Industrial Testing Applications, Research
Applications, Other Applications
·
By End-User: Diagnostic Laboratories & Hospitals, Pharmaceutical &
Biotechnology Companies, Food & Beverage Companies, Contract Research
Organizations (CROs), Academic & Research Institutes, Environmental Testing
Laboratories, Other End-Users
·
By Region: North America, Europe, Asia-Pacific, Latin America, Middle East &
Africa
Rapid Microbiology Testing Market Product Type Segment Review
Instruments held the greatest market share of
XX.X% in 2023 as they are essential components of rapid microbiology testing systems,
facilitating the detection, identification, and analysis of microorganisms in
various samples. Essential consumables for sample preparation, amplification,
and microbiological target detection include kits and reagents, which are
utilized in combination with fast microbiology testing equipment. Disposable
consumables expedite workflow, lessen the possibility of cross-contamination
between samples, and make instrument maintenance and cleaning processes easier.
Rapid Microbiology Testing Market Testing Method Segment Review
Rapid pathogen identification is achieved by the
detection and amplification of microbial nucleic acids, such as DNA or RNA,
using nucleic acid-based technologies. Rapid microbiological testing frequently
uses nucleic acid-based methods such as polymerase chain reaction (PCR),
real-time PCR (qPCR), loop-mediated isothermal amplification (LAMP), and
nucleic acid sequencing. At XX.X%, it had the most market share in 2023. For
instance, the fast RT-PCR Accula Flu A/Flu B test was released by Thermo Fisher
Scientific Inc. (US) in November 2022. For thorough microbiological
investigation and testing for antibiotic susceptibility, growth-based testing
is still crucial even though it isn't as quick as certain molecular techniques.
Rapid Microbiology Testing Market Application Segment Review
Application areas for industrial testing include
the food and beverage, pharmaceutical, cosmetic, and biotechnology industries.
Rapid microbiological testing is used in these sectors. Because of their strict
safety requirements, these applications had the biggest market share of XX.X%
in 2023. The identification of microbial pathogens in clinical samples and
their detection constitute the second-largest application area of fast
microbiology testing, after sample preparation. To investigate disease causes,
characterize microbial populations, and explore microbial ecology, researchers
use quick testing.
Rapid Microbiology Testing Market End-User Segment Review
Rapid microbiological testing solutions are widely
utilized by diagnostic laboratories and hospitals for clinical disease
diagnosis and patient care. Rapid microbiological testing is essential to
pharmaceutical and biotechnology businesses for regulatory compliance, process
monitoring, and quality control in medication manufacturing. CROs assist their
clients with product development and regulatory filings by providing technical
knowledge in method development, validation, and testing services for
microbiological assays. Rapid microbiology testing technologies are used by
research and academic institutions for both fundamental and applied
microbiological, infectious disease, environmental science, and biotechnology
research.
Rapid Microbiology Testing Market Regional Synopsis:
Modern healthcare facilities and stringent
regulations, especially in the US and Canada, support the quick microbiological
testing industry in North America. With a focus on accurate microbiological
testing and clinical laboratory operations, the region's robust adoption of
point-of-care testing (POCT) and molecular diagnostics propels market
expansion. For quick microbial identification and infection management, Bruker,
for instance, introduced new microbiology products and workflows in July 2021.
Robust food safety rules and well-established
healthcare systems have created a substantial market for quick microbial
testing in Europe. Advanced technologies like mass spectrometry and molecular
diagnostics are used by important nations like Germany, the UK, France, and
Italy to guarantee the quality and safety of food goods and clinical
diagnostics. Technological advancements and industry-regulatory body
partnerships facilitate market development in several industries.
With rising healthcare expenditure, higher
awareness of infectious illnesses, and enhanced food safety requirements, Asia
Pacific particularly China and India is emerging as a prominent player in the
rapidly growing microbiological testing market. The market is expected to
develop at a significant rate between 2024 and 2034. The population expansion,
urbanization, and industrialization of nations such as China, India, Japan, and
South Korea drive enormous demand. The market is expanding for applications
related to environmental monitoring, food safety, and clinical monitoring,
thanks to government efforts and investments in healthcare infrastructure.
Rapid microbiological testing is growing in Latin
America and the Middle East/Africa due to attempts to improve food safety and
clinical diagnostics, as well as rising healthcare spending. Prominent nations
such as Brazil, Mexico, Argentina, Colombia, Saudi Arabia, South Africa, and
the United Arab Emirates place emphasis on regulating foodborne diseases,
enhancing environmental surveillance, and fortifying healthcare systems via partnerships
with regulatory bodies, hence propelling the market growth.
Rapid Microbiology Testing Market Key Challenges:
Rapid microbiological testing has serious
challenges due to the global growth in antimicrobial resistance (AMR), which
makes it necessary to accurately and quickly identify drug-resistant organisms to
make treatment decisions. However, due to the variety of resistance mechanisms
and the requirement for thorough susceptibility testing, identifying and
characterizing AMR strains using quick assays can be challenging. Fighting the
spread of drug-resistant diseases requires the development of quick diagnostic
techniques that identify AMR indicators and provide useful information to
direct antimicrobial therapy.
One problem is ensuring that quick microbial
testing procedures are validated and standardized across various businesses,
laboratories, and regulatory countries. Inter-laboratory comparability and
regulatory compliance are hampered by inconsistent testing outcomes caused by
variations in testing techniques, tools, reagents, and result interpretation.
Addressing this issue and fostering trust in quick test findings requires the
establishment of standardized procedures, reference materials, and proficiency
testing programs.
Handling diverse sample matrices, such as food,
environmental, and clinical samples, presents difficulties for rapid
microbiological testing because they include toxins, inhibitors, or background
microbiota that affect the sensitivity and accuracy of the test. For manufacturers
and academics, one of the biggest challenges is continuing to develop quick
testing procedures that handle a variety of sample types while retaining
specificity and reproducibility.
Rapid Microbiology Testing Market Key Global Players:
The competitive landscape of the rapid
microbiology testing market is shaped by several factors, including:
·
Adherence to regulatory bodies such
as the FDA, EMA, and ISO is vital for maintaining competitiveness and
demonstrates a commitment to the safety and quality of products. Getting
regulatory clearances facilitates market access and improves reputation.
·
By adapting to changing consumer
demands, constant innovation in technologies like automation and molecular
diagnostics provides a competitive edge. Innovation in fields including
automation, mass spectrometry, microfluidics, and molecular diagnostics enables
businesses to provide cutting-edge solutions that satisfy changing end-user
demands.
·
Successfully broadening the market's
reach and exposure requires robust distribution networks and well-crafted
market penetration tactics. Firms enhance their market penetration and augment
product exposure by forming alliances with distributors, clinical laboratories,
healthcare establishments, food producers, and research organizations.
·
Market positioning is improved and
customer loyalty is fostered by providing a varied product range with
distinctive characteristics and value-added services. A competitive advantage
is enjoyed by businesses that offer complete solutions, which include
equipment, consumables, reagents, software, and support services.
Numerous players are vying for market share and
investing in new technologies and product development to stay ahead of the
curve in the market. Several key global players in the rapid microbiology
testing market include:
·
Danaher Corporation
·
bioMérieux SA
·
Thermo Fisher Scientific Inc.
·
Becton, Dickinson, and Company
·
Neogen Corporation
·
Bruker Corporation
·
Merck KGaA
·
Rapid Micro Biosystems, Inc.
·
F. Hoffmann-La Roche AG
·
Shimadzu Corporation
·
Agilent Technologies, Inc.
·
Bio-Rad Laboratories, Inc.
·
Sartorius AG
·
Abbott
·
IDEXX Laboratories, Inc.
·
Other Players
The report on the rapid microbiology
testing market covers the following aspects:
·
Market Overview: A general overview
of the global rapid microbiology testing market, including its current size and
growth projections for the future.
·
Market Segmentation: A market
breakdown by product type, testing method, application, end-user, and
geographic regions.
·
Market Dynamics: An analysis of the
key drivers, challenges, and trends affecting the growth of the rapid
microbiology testing market.
·
Competitive Landscape: A
comprehensive analysis of the leading players in the rapid microbiology testing
market, including their market share, product offerings, and key strategies.
·
Regional Analysis: A detailed
analysis of the rapid microbiology testing market by geographic region,
including market size, growth projections, and key trends for each region.
·
Company Profiles: In-depth profiles
of key players in the rapid microbiology testing market, including their
business overview, product offerings, financial performance, and recent
developments.
· Market Forecast: Projections for the future growth of the rapid microbiology testing market, including market size, growth rate, and key trends for the next five to ten years.
Attributes |
Details |
Base Year |
2023 |
Trend Period |
2023 – 2034 |
Forecast Period |
2024 – 2034 |
Pages |
215 |
By Product
Type Segment |
Instruments,
Reagents & Kits, Consumables |
By
Testing Method Segment |
Growth-Based
Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology
Testing, Nucleic Acid-Based Rapid Microbiology Testing, Viability-Based Rapid
Microbiology Diagnostic Testing, Other Rapid Microbiology Testing Methods |
By Application
Segment |
Clinical
Disease Diagnosis, Industrial Testing Applications, Research Applications,
Other Applications |
By
End-User Segment |
Diagnostic
Laboratories & Hospitals, Pharmaceutical & Biotechnology Companies,
Food & Beverage Companies, Contract Research Organizations (CROs),
Academic & Research Institutes, Environmental Testing Laboratories, Other
End-Users
|
Company Profiles |
Danaher Corporation,
bioMérieux SA, Thermo Fisher Scientific Inc., Becton, Dickinson and Company,
Neogen Corporation, Bruker Corporation, Merck KGaA, Rapid Micro Biosystems,
Inc., F. Hoffmann-La Roche AG, Shimadzu Corporation, Agilent Technologies,
Inc., Bio-Rad Laboratories, Inc., Sartorius AG, Abbott, IDEXX Laboratories,
Inc., and Other Players |
Edition |
4th edition |
Publication |
April 2024 |